Gallbladder cancer: A subtype of biliary tract cancer which is a current challenge in China

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 4, 2012, Pages 1317-1320

  Qu, Kai ^a   Liu, Si Nan ^a   Chang, Hu Lin ^a   Liu, Chang ^a   Xu, Xin Sen ^a   Wang, Rui Tao ^a   Zhou, Lei ^a   Tian, Feng ^a   Wei, Ji Chao ^a   Tai, Ming Hui ^a   Meng, Fan Di ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Biliary tract cancer; China; Epidemiology; Gallbladder cancer; Treatment

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; BLOOD; CANCER INVASION; CANCER STAGING; CHINA; FEMALE; GALLBLADDER TUMOR; HEPATIC DUCT; HUMAN; INTRAHEPATIC BILE DUCT; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-FETOPROTEINS; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; BILE DUCTS, INTRAHEPATIC; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHINA; CHOLANGIOCARCINOMA; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84873019020     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.4.1317     Document Type: Article

References (16)

1. Aljiffry M, Walsh MJ, Molinari M (2009). Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol, 15, 4240-62.
2. Bartlett DL, Fong Y, Fortner JG, et al (1996). Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg, 224, 639-46.
3. Dixon E, Vollmer CM Jr, Sahajpal A, et al (2005). An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg, 241, 385-94.
4. Hueman MT, Vollmer CM Jr, Pawlik TM (2009). Evolving treatment strategies for gallbladder cancer. Ann Surg Oncol, 16, 2101-15.
5. Lazcano-Ponce EC, Miquel JF, Muñoz N, et al (2001). Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin, 51, 349-64.
6. Onori P, Gaudio E, Franchitto A, et al (2010). Histamine regulation of hyperplastic and neoplastic cell growth in cholangiocytes. World J Gastrointest Pathophysiol, 1, 38-49.
7. Patel T (2002). Worldwide trends in mortality from biliary tract malignancies. BMC Cancer, 2, 10.
8. de Groen PC, Gores GJ, LaRusso NF, et al (1999). Biliary tract cancers. N Engl J Med, 341, 1368-78.
9. Patel T (2004). Worldwide trends in mortality from biliary tract malignancies. BMC Cancer, 2, 10.
10. Rajagopalan H, Lengauer C (2004). Aneuploidy and cancer. Nature, 432, 338-41.
11. Randi G, Franceschi S, La Vecchia C (2006). Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer, 118, 1591-602.
12. Shrikhande SV, Barreto SG, Singh S, et al (2010). Cholelithiasis in gallbladder cancer: coincidence, cofactor, or cause! Eur J Surg Oncol, 36, 514-9.
13. Song SC, Heo JS, Choi DW, et al (2011). Survival benefits of surgical resection in recurrent cholangiocarcinoma. J Korean Surg Soc, 81, 187-94.
14. Welzel TM, McGlynn KA, Hsing AW, et al (2006). Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst, 98, 873-5.
15. Wistuba II, Gazdar AF (2004). Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer, 4, 695-706.
16. Wolpin BM, Mayer RJ (2010). A step forward in the treatment of advanced biliary tract cancer. N Engl J Med, 362, 1335-7